Free Account Opening + AMC Free Demat
Loading...

Brooks Laboratories Rights Issue 2023 vs Credent Global Finance Rights Issue 2023

Comparision between Brooks Laboratories Rights Issue 2023 and Credent Global Finance Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Brooks Laboratories Rights Issue 2023 and Credent Global Finance Rights Issue 2023. Brooks Laboratories Rights Issue 2023 is listed on BSE, NSE while Credent Global Finance Rights Issue 2023 is listed on BSE.

  Brooks Laboratories Limited Credent Global Finance Limited
Logo Brooks Laboratories Rights Issue 2023 Logo Credent Global Finance Rights Issue 2023 Logo
Listing At BSE, NSE BSE
Terms of Payment

Full amount of Rs. 75 for rights equity shares has to be paid on application.

On Application, Investors will have to pay Rs. 140 per Rights Equity Share, which constitutes 100% of the Issue price.

Entitlement 1 Rights Equity Share(s) for every 16 fully paid-up Equity Shares held on Record Date 1 Rights Equity Share(s) for every 2 fully paid-up Equity Shares held on Record Date
Application Form Application Form Application Form
Letter of Offer Letter of Offer Letter of Offer
Registrar Link Intime India Private Ltd Beetal Financial & Computer Services (P) Limited
Lead Managers

Rights Issue Size and Price

The issue size of Brooks Laboratories Rights Issue 2023 rights issue is ₹11.58 Crores, whereas Credent Global Finance Rights Issue 2023 rights issue size is ₹48.56 Crores.

  Brooks Laboratories Limited Credent Global Finance Limited
Issue Size 15,43,926 shares 34,68,750 shares
Issue Size (Amount) ₹11.58 Crores ₹48.56 Crores
Issue Price ₹75 per share ₹140 per share
Face Value ₹10 per share ₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Brooks Laboratories Rights Issue 2023 is Jul 28, 2023 while record date of Credent Global Finance Rights Issue 2023 is Jul 17, 2023.

  Brooks Laboratories Limited Credent Global Finance Limited
Record Date Jul 28, 2023 Jul 17, 2023
Credit of Rights Entitlements Aug 03, 2023 Jul 24, 2023
Bid/Offer Opens On Aug 07, 2023 Jul 25, 2023
Renunciation of Rights Entitlements Aug 17, 2023 Aug 10, 2023
Bid/Offer Closes On Aug 22, 2023 Aug 14, 2023
Deemed Date of Allotment Aug 29, 2023 Aug 14, 2023
Credit Date Aug 30, 2023 Aug 17, 2023
Listing Date Sep 01, 2023 Aug 21, 2023

Financials details

Comparison of Brooks Laboratories Rights Issue 2023 and Credent Global Finance Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

  Brooks Laboratories Limited Credent Global Finance Limited
Financial
Brooks Laboratories Rights Issue 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 202231 Mar 2023
Assets195.91109.60
Revenue91.9963.41
Profit After Tax-18.31-31.05
Net Worth
Reserves and Surplus
Total Borrowing
Amount in ₹ Crore
Credent Global Finance Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-227.921.901.07
31-Mar-2375.8019.576.74
Amount in ₹ Crore

Comments

Add a public comment...